Risk factors for atherosclerosis development in patients with systemic scleroderma

Systemic scleroderma (SSc), also known as systemic sclerosis, is a rare autoimmune disorder characterized by fibrosis of the skin and internal organs, as well as vascular abnormalities. Atherosclerosis, the accumulation of lipids and fibrous tissue in arterial walls, is a significant cause of cardiovascular morbidity and mortality. Patients with systemic scleroderma are at an elevated risk for developing atherosclerosis, with vascular damage playing a central role in its pathogenesis. This article reviews the multifactorial risk factors contributing to the development of atherosclerosis in patients with systemic scleroderma, focusing on endothelial dysfunction, chronic inflammation, dyslipidemia, and other clinical factors. The goal of this article is to enhance the understanding of cardiovascular risk in this population and emphasize the importance of early diagnosis and targeted interventions.

Authors

Publication Details

Journal
American Journal Of Biomedical Science & Pharmaceutical Innovation
Published
2025-02-01
DOI
https://doi.org/10.37547/ajbspi/volume05issue02-05
Primary Topic
Systemic Sclerosis and Related Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk factors for atherosclerosis development in patients with systemic scleroderma

Krit Dwivedi, Zanchetta Cardoso Eid K, Vinayak Koli, Ganieva N.A.
American Journal Of Biomedical Science & Pharmaceutical Innovation
Systemic Sclerosis and Related Diseases
article

Risk factors for atherosclerosis development in patients with systemic scleroderma

Krit Dwivedi, Zanchetta Cardoso Eid K, Vinayak Koli, Ganieva N.A.
article en

Abstract

Systemic scleroderma (SSc), also known as systemic sclerosis, is a rare autoimmune disorder characterized by fibrosis of the skin and internal organs, as well as vascular abnormalities. Atherosclerosis, the accumulation of lipids and fibrous tissue in arterial walls, is a significant cause of cardiovascular morbidity and mortality. Patients with systemic scleroderma are at an elevated risk for developing atherosclerosis, with vascular damage playing a central role in its pathogenesis. This article reviews the multifactorial risk factors contributing to the development of atherosclerosis in patients with systemic scleroderma, focusing on endothelial dysfunction, chronic inflammation, dyslipidemia, and other clinical factors. The goal of this article is to enhance the understanding of cardiovascular risk in this population and emphasize the importance of early diagnosis and targeted interventions.

American Journal Of Biomedical Science & Pharmaceutical InnovationVol. 5(2)
Openalex Percentile: Top 96%
Systemic Sclerosis and Related Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Risk factors for atherosclerosis development in patients with systemic scleroderma — Krit Dwivedi, Zanchetta Cardoso Eid K, et al. · American Journal Of Biomedical Science & Pharmaceutical Innovation (2025) | TGRS Research Map | TGRS